Supernus Pharmaceuticals (SUPN) Tax Rate Growth (3y) (2018 - 2025)
Supernus Pharmaceuticals (SUPN) Tax Rate Growth (3y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.39 Bn | 30.45 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.59 Bn | 23.53 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.19 Bn | 21.04 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.27 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 18.00 Bn | 16.69 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.37 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14,188.00 |
| Sep 30, 2025 | -47,177.00 |
| Jun 30, 2025 | -6,552.00 |
| Mar 31, 2025 | -2,880.00 |
| Dec 31, 2024 | 6,096.00 |
| Sep 30, 2024 | -1,131.00 |
| Jun 30, 2024 | 29.00 |
| Mar 31, 2024 | -675.00 |
| Dec 31, 2023 | -4,117.00 |
| Sep 30, 2023 | 23,743.00 |
| Mar 31, 2023 | -11,384.00 |
| Dec 31, 2022 | 839.00 |
| Sep 30, 2022 | 46,682.00 |
| Jun 30, 2022 | 711.00 |
| Mar 31, 2022 | -9,837.00 |
| Dec 31, 2021 | -5,227.00 |
| Sep 30, 2021 | 256.00 |
| Jun 30, 2021 | 1,483.00 |
| Mar 31, 2021 | 3,241.00 |
| Dec 31, 2020 | -3,856.00 |